indomethacin has been researched along with Hyaline Membrane Disease in 7 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
Hyaline Membrane Disease: A respiratory distress syndrome in newborn infants, usually premature infants with insufficient PULMONARY SURFACTANTS. The disease is characterized by the formation of a HYALINE-like membrane lining the terminal respiratory airspaces (PULMONARY ALVEOLI) and subsequent collapse of the lung (PULMONARY ATELECTASIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| " Four had severe hyaline membrane disease and one had chronic bronchopulmonary dysplasia; all received furosemide." | 3.66 | Urinary excretion of prostaglandin E following the administration of furosemide and indomethacin to sick low-birth-weight infants. ( Demers, LM; Friedman, Z; Maisels, MJ; Marks, KH; Uhrmann, S, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, VY | 1 |
| Cooke, RW | 1 |
| Pickering, D | 1 |
| Csaba, IF | 1 |
| Sulyok, E | 1 |
| Ertl, T | 1 |
| Friedman, Z | 1 |
| Demers, LM | 1 |
| Marks, KH | 1 |
| Uhrmann, S | 1 |
| Maisels, MJ | 1 |
| Steinberg, JD | 1 |
| Bambang Oetomo, S | 1 |
| Martijn, A | 1 |
| Schuster, V | 1 |
| von Stockhausen, HB | 1 |
| Seyberth, HW | 1 |
| Krauss, AN | 1 |
| Fatica, N | 1 |
| Lewis, BS | 1 |
| Cooper, R | 1 |
| Thaler, HT | 1 |
| Cirrincione, C | 1 |
| O'Loughlin, J | 1 |
| Levin, A | 1 |
| Engle, MA | 1 |
| Auld, PA | 1 |
7 other studies available for indomethacin and Hyaline Membrane Disease
| Article | Year |
|---|---|
Patent ductus arteriosus in preterm infants.
Topics: Ductus Arteriosus, Patent; Heart Failure; Humans; Hyaline Membrane Disease; Indomethacin; Infant, Ne | 1980 |
Poor response to oral indomethacin therapy for persistent ductus arteriosus in very low birthweight infants.
Topics: Ductus Arteriosus, Patent; Humans; Hyaline Membrane Disease; Indomethacin; Infant; Infant, Low Birth | 1979 |
Urinary excretion of prostaglandin E and F 2 alpha in healthy newborn infants and in infants with hyaline membrane disease.
Topics: Humans; Hyaline Membrane Disease; Indomethacin; Infant, Newborn; Infant, Premature; Male; Prostaglan | 1979 |
Urinary excretion of prostaglandin E following the administration of furosemide and indomethacin to sick low-birth-weight infants.
Topics: Calcium; Drug Antagonism; Ductus Arteriosus, Patent; Female; Furosemide; Humans; Hyaline Membrane Di | 1978 |
Asymmetrical pulmonary changes in premature infants with surgical closure of a persistent ductus arteriosus.
Topics: Bronchopulmonary Dysplasia; Ductus Arteriosus, Patent; Humans; Hyaline Membrane Disease; Indomethaci | 1990 |
Effects of highly overdosed indomethacin in a preterm infant with symptomatic patent ductus arteriosus.
Topics: Drug Overdose; Ductus Arteriosus, Patent; Humans; Hyaline Membrane Disease; Indomethacin; Infant, Ne | 1990 |
Pulmonary function in preterm infants following treatment with intravenous indomethacin.
Topics: Ductus Arteriosus, Patent; Humans; Hyaline Membrane Disease; Indomethacin; Infant, Newborn; Infant, | 1989 |